629 related articles for article (PubMed ID: 23818515)
1. The pneumococcus: epidemiology, microbiology, and pathogenesis.
Henriques-Normark B; Tuomanen EI
Cold Spring Harb Perspect Med; 2013 Jul; 3(7):. PubMed ID: 23818515
[TBL] [Abstract][Full Text] [Related]
2. Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen.
Subramanian K; Henriques-Normark B; Normark S
Cell Microbiol; 2019 Nov; 21(11):e13077. PubMed ID: 31251447
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance. Epidemiology of antibiotic resistance: blood and cerebrospinal fluid (CSF).
Johnson AP; Speller DC
J Med Microbiol; 1997 Jun; 46(6):445-7. PubMed ID: 9379470
[No Abstract] [Full Text] [Related]
4. In Vivo Mouse Models to Study Pneumococcal Host Interaction and Invasive Pneumococcal Disease.
Iovino F; Sender V; Henriques-Normark B
Methods Mol Biol; 2019; 1968():173-181. PubMed ID: 30929214
[TBL] [Abstract][Full Text] [Related]
5. The fundamental link between pneumococcal carriage and disease.
Simell B; Auranen K; Käyhty H; Goldblatt D; Dagan R; O'Brien KL;
Expert Rev Vaccines; 2012 Jul; 11(7):841-55. PubMed ID: 22913260
[TBL] [Abstract][Full Text] [Related]
6. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria.
Falade AG; Lagunju IA; Bakare RA; Odekanmi AA; Adegbola RA
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S190-6. PubMed ID: 19191615
[TBL] [Abstract][Full Text] [Related]
7. Mucosal Infections and Invasive Potential of Nonencapsulated
Bradshaw JL; Pipkins HR; Keller LE; Pendarvis JK; McDaniel LS
mBio; 2018 Jan; 9(1):. PubMed ID: 29339428
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
9. [Pneumococcus pathogenicity factors and their protective properties].
Kostiukova NN; Bekhalo VA
Zh Mikrobiol Epidemiol Immunobiol; 2014; (3):67-77. PubMed ID: 25286514
[TBL] [Abstract][Full Text] [Related]
10. Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization.
Gilley RP; Orihuela CJ
Front Cell Infect Microbiol; 2014; 4():163. PubMed ID: 25414838
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal colonization and invasive disease studied in a porcine model.
de Greeff A; van Selm S; Buys H; Harders-Westerveen JF; Tunjungputri RN; de Mast Q; van der Ven AJ; Stockhofe-Zurwieden N; de Jonge MI; Smith HE
BMC Microbiol; 2016 Jun; 16():102. PubMed ID: 27276874
[TBL] [Abstract][Full Text] [Related]
12. Capsule Type and Amount Affect Shedding and Transmission of
Zafar MA; Hamaguchi S; Zangari T; Cammer M; Weiser JN
mBio; 2017 Aug; 8(4):. PubMed ID: 28830943
[TBL] [Abstract][Full Text] [Related]
13. Natural transformation and genome evolution in Streptococcus pneumoniae.
Straume D; Stamsås GA; Håvarstein LS
Infect Genet Evol; 2015 Jul; 33():371-80. PubMed ID: 25445643
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.
AlonsoDeVelasco E; Verheul AF; Verhoef J; Snippe H
Microbiol Rev; 1995 Dec; 59(4):591-603. PubMed ID: 8531887
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
[TBL] [Abstract][Full Text] [Related]
16. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.
Ogunniyi AD; LeMessurier KS; Graham RM; Watt JM; Briles DE; Stroeher UH; Paton JC
Infect Immun; 2007 Apr; 75(4):1843-51. PubMed ID: 17261599
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and molecular characterization of Streptococcus pneumoniae serotype 6C causing invasive disease in Gipuzkoa, northern Spain, 1990-2009.
Marimon JM; Ercibengoa M; Alonso M; García-Medina G; Pérez-Trallero E
Eur J Clin Microbiol Infect Dis; 2010 Aug; 29(8):1035-8. PubMed ID: 20467771
[TBL] [Abstract][Full Text] [Related]
18. The impact of the ancillary pilus-1 protein RrgA of Streptococcus pneumoniae on colonization and disease.
Iovino F; Nannapaneni P; Henriques-Normark B; Normark S
Mol Microbiol; 2020 Mar; 113(3):650-658. PubMed ID: 32185835
[TBL] [Abstract][Full Text] [Related]
19. Transformation of nonencapsulated Streptococcus pneumoniae during systemic infection.
Bradshaw JL; Rafiqullah IM; Robinson DA; McDaniel LS
Sci Rep; 2020 Nov; 10(1):18932. PubMed ID: 33144660
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccines.
Manoharan A; Jayaraman R
Indian J Med Microbiol; 2018; 36(4):465-474. PubMed ID: 30880692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
